[Physiopathology of the dyskinesias induced by L-dopa].
Dyskinesias are one of most frequent motor complications of parkinsonian patients on chronic levodopa treatment. This article reviews their clinical characteristics, risk factors, pathophysiology and possible therapeutical approaches.
Grandas
F
F
Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, España.
López-Ariztegui
N
N
D017668:Age of Onset; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D012720:Severity of Illness Index
D000978:Antiparkinson Agents; D007980:Levodopa